ClinicalTrials.gov
ClinicalTrials.gov Menu

Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00463203
Recruitment Status : Completed
First Posted : April 20, 2007
Last Update Posted : June 29, 2011
Sponsor:
Information provided by:
Rigshospitalet, Denmark

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2011
  Actual Study Completion Date : June 2011